PE20091362A1 - Derivados de gamma-lactona del esteroide del acido 17-hidroxi-19-nor-21-carboxilico y composiciones que los contienen - Google Patents

Derivados de gamma-lactona del esteroide del acido 17-hidroxi-19-nor-21-carboxilico y composiciones que los contienen

Info

Publication number
PE20091362A1
PE20091362A1 PE2008002191A PE2008002191A PE20091362A1 PE 20091362 A1 PE20091362 A1 PE 20091362A1 PE 2008002191 A PE2008002191 A PE 2008002191A PE 2008002191 A PE2008002191 A PE 2008002191A PE 20091362 A1 PE20091362 A1 PE 20091362A1
Authority
PE
Peru
Prior art keywords
alkyl
gamma
hydroxy
lactone
carboxyl
Prior art date
Application number
PE2008002191A
Other languages
English (en)
Inventor
Klar Ulrich
Joachim Kuhnke
Rolf Bohlmann
Jan Huebner
Sven Ring
Thomas Frenzel
Frederik Menges
Steffen Borden
Hans-Peter Muhn
Katja Prelle
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of PE20091362A1 publication Critical patent/PE20091362A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J19/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 by a lactone ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)

Abstract

REFERIDA A UN DERIVADO DE GAMMA-LACTONA DEL ESTEROIDE DEL ACIDO 17-HIDROXI-19-NOR-21-CARBOXILICO DE FORMULA (I), DONDE Z ES OXIGENO, H, NOR', NNHSO2R'; R' ES H, ALQUILO C1-C10, ARILO O ARALQUILO C7-C20; R4 ES H O HALOGENO; R6a Y R6b SON H, ALQUILO C1-C10, ALQUENILO C2-C10, ENTRE OTROS; R7 ES H, ALQUILO C1-C10, ALQUINILO C2-C10, CICLOALQUILO C3-C6, ENTRE OTROS; R15 ES H; R16a Y R16b SON H, ALQUILO C1-C10, ENTRE OTROS; R18 ES H O ALQUILO C1-C3. SON COMPUESTOS PREFERIDOS: GAMMA-LACTONA DEL ACIDO 17BETA-HIDROXI-7ALFA-METIL-19-NOR-17ALFA-PREGNA-4,20(Z)-DIEN-3-ONA-21-CARBOXILICO, GAMMA-LACTONA DEL ACIDO 17BETA-HIDROXI-7BETA-METIL-19-NOR-17ALFA-PREGNA-4,20(Z)-DIEN-3-ONA-21-CARBOXILICO, GAMMA-LACTONA DEL ACIDO 17BETA-HIDROXI-7ALFA-ETIL-19-NOR-17ALFA-PREGNA-4,20(Z)-DIEN-3-ONA-21-CARBOXILICO, ENTRE OTROS. TAMBIEN ESTA REFERIDA A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS TIENEN ACTIVIDAD GESTAGENICA Y SON UTILES EN EL TRATAMIENTO DE TRANSTORNOS MENOPAUSICOS Y MOLESTIAS PREMENSTRUALES, ENTRE OTROS
PE2008002191A 2007-12-29 2008-12-29 Derivados de gamma-lactona del esteroide del acido 17-hidroxi-19-nor-21-carboxilico y composiciones que los contienen PE20091362A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102007063503A DE102007063503A1 (de) 2007-12-29 2007-12-29 17-Hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
PE20091362A1 true PE20091362A1 (es) 2009-10-15

Family

ID=40481980

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008002191A PE20091362A1 (es) 2007-12-29 2008-12-29 Derivados de gamma-lactona del esteroide del acido 17-hidroxi-19-nor-21-carboxilico y composiciones que los contienen

Country Status (22)

Country Link
US (1) US8937058B2 (es)
EP (1) EP2238151A1 (es)
JP (1) JP5600068B2 (es)
KR (1) KR20100102688A (es)
CN (1) CN101910190A (es)
AR (1) AR069966A1 (es)
AU (1) AU2008342910A1 (es)
BR (1) BRPI0821922A2 (es)
CA (1) CA2710491C (es)
CL (1) CL2008003918A1 (es)
CO (1) CO6300845A2 (es)
CR (1) CR11545A (es)
DE (1) DE102007063503A1 (es)
DO (1) DOP2010000198A (es)
EC (1) ECSP10010318A (es)
IL (1) IL206379A0 (es)
PA (1) PA8809701A1 (es)
PE (1) PE20091362A1 (es)
TW (1) TW200940073A (es)
UY (1) UY31584A1 (es)
WO (1) WO2009083266A1 (es)
ZA (1) ZA201005396B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007063503A1 (de) 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
WO2012059594A1 (en) 2010-11-04 2012-05-10 Bayer Pharma Aktiengesellschaft Mineralcorticoid receptor antagonists for the treatment of corticoid-induced obesity

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2918463A (en) 1958-06-12 1959-12-22 Searle & Co 17-carboxyalkylated 17-hydroxy-19-norandrosten-3-ones
US3194803A (en) * 1960-04-28 1965-07-13 Searle & Co Process and intermediates for the manufacture of 3-keto-delta4, 6 steroids
US3254074A (en) * 1962-04-25 1966-05-31 Merck & Co Inc Spiroxenones
DE1183500B (de) 1962-10-12 1964-12-17 Schering Ag Verfahren zur Herstellung von alpha, beta-Methylenketonen der Steroidreihe
US3705179A (en) 1971-03-15 1972-12-05 American Home Prod Antiandrogenic steroids
US3764596A (en) * 1971-06-22 1973-10-09 Sandoz Ag 17-dihydrofuranyl-substituted steroids
NL7701384A (nl) 1977-02-10 1978-08-14 Akzo Nv Werkwijze voor het bereiden van nieuwe steroiden van de oestraanreeks.
DE2922500A1 (de) 1979-05-31 1980-12-04 Schering Ag 6 beta .7 beta
DE3022337A1 (de) * 1980-06-11 1982-01-07 Schering Ag Berlin Und Bergkamen, 1000 Berlin Praeparate zur kontrazeption und zur behandlung gynaekologischer stoerungen
JPS59139400A (ja) * 1983-01-31 1984-08-10 Shionogi & Co Ltd 抗アルドステロン活性ステロイド誘導体
DE3402329A1 (de) 1984-01-20 1985-08-01 Schering AG, 1000 Berlin und 4709 Bergkamen 6,6-ethylen-15,16-methylen-3-oxo-17(alpha)-pregn-4-en-21,17-carbolactone, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
DE3410880A1 (de) * 1984-03-21 1985-10-03 Schering AG, Berlin und Bergkamen, 1000 Berlin 17-substituierte estradiene und estratriene
DE3426771C2 (de) * 1984-07-07 1997-03-20 Schering Ag 13alpha-Methylgonane, deren Herstellung und Verwendung
DE4232521A1 (de) * 1992-09-22 1994-03-24 Schering Ag Gestagen wirksame 4,5;11,12-Estradiene, Verfahren zu ihrer Herstellung, diese Estradiene enthaltende Arzneimittel sowie deren Verwendung zur Herstellung von Arzneimitteln
DE4447401A1 (de) 1994-12-23 1996-07-04 Schering Ag 14,17-C¶2¶-überbrückte Steroide
DE19651000A1 (de) 1996-12-01 1998-06-04 Schering Ag Oxyiminopregnancarbolactone
DE102004063864A1 (de) 2004-12-30 2006-07-13 Schering Ag 18-Methyl-19-nor-17-pregn-4-en21,17-carbolactone, sowie diese enthaltende pharmazeutische Präparate
DE102007063503A1 (de) 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel

Also Published As

Publication number Publication date
JP2011507924A (ja) 2011-03-10
BRPI0821922A2 (pt) 2015-06-16
JP5600068B2 (ja) 2014-10-01
AR069966A1 (es) 2010-03-03
CR11545A (es) 2010-08-27
DE102007063503A1 (de) 2009-07-02
CA2710491C (en) 2015-11-03
CA2710491A1 (en) 2009-07-09
CL2008003918A1 (es) 2010-01-15
PA8809701A1 (es) 2009-07-23
CN101910190A (zh) 2010-12-08
ECSP10010318A (es) 2010-08-31
CO6300845A2 (es) 2011-07-21
ZA201005396B (en) 2012-01-25
WO2009083266A1 (de) 2009-07-09
US8937058B2 (en) 2015-01-20
DOP2010000198A (es) 2010-08-31
UY31584A1 (es) 2009-08-03
TW200940073A (en) 2009-10-01
AU2008342910A1 (en) 2009-07-09
EP2238151A1 (de) 2010-10-13
US20110021472A1 (en) 2011-01-27
IL206379A0 (en) 2010-12-30
KR20100102688A (ko) 2010-09-24

Similar Documents

Publication Publication Date Title
NO20090835L (no) Nye HIV-reverstranskriptaseinhibitorer
NO20081315L (no) Benzokinazolinderivater og deres anvendelse ved behandling av benlidelser
MX2009006756A (es) Derivados de 1-amino-metil-l-fenil-ciclohexano como inhibidores de dpp-iv.
ZA201002690B (en) N-phenyl-dioxo-hydropyrimidines useful as hepatitis c virus (hcv) inhibitors
NO20082090L (no) Pyridopyrimidinoninhibitorer av P13K alfa
SV2010003598A (es) Derivados de tiazol usados como inhibidores de pi 3-cinasa
PA8848201A1 (es) Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa-iv para el tratamiento o prevención de diabetes
EA200971115A1 (ru) Новые ингибиторы обратной транскриптазы вич
ECSP088972A (es) Isoindoles sustituidos como inhibidores de bace y su uso
MX2007011695A (es) Derivados de oxindol sustituido, medicamentos que contienen dichos derivados y uso de los mismos.
ECSP088103A (es) Nuevos derivados de 2-azetidinona como inhibidores de la absorción del colesterol para el tratamiento de condiciones de hiperlipidemia
NO20080865L (no) Spirokromanonderivater som acetyl-koenzym-A-karboksylase(ACC)inhibitorer
UY28877A1 (es) Compuestos de metil-aril o heteroaril-amida sustituida y composiciones
PE20120058A1 (es) Derivados de imidazopirazina como inhibidores de syk
EA201100750A1 (ru) Замещенные диоксопиперидинилфталимидные производные
ECSP045004A (es) Inhibidores de la 17beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades andrógeno dependientes
UA108743C2 (uk) Похідні хіназолін-4(3н)-ону для застосування як інгібіторів рі3-кінази
ATE473221T1 (de) 1-(1-benzylpiperidin-4-yl)benzimidazol-5- carbonsäurederivate zur behandlung von diabetes mellitus
PE20170084A1 (es) Derivados de 17-hidroxi-17-pentafluoroetil-estra-4-9(10)-dien-11-arilo como antagonistas de progesterona y procedimientos para su preparacion
ECSP11010830A (es) Derivados de heteroarilo como inhibidores de dgat1
DK2207770T3 (da) 1, 2, 3-triazolderivater til anvendelse som stearoyl-coa desaturase-inhibitorer
MX2007011698A (es) Derivados de oxindol sustituido, medicamentos que contienen dichos derivados y uso de los mismos.
AR036248A1 (es) Derivados de 2h-piridazin-3-ona, composiciones farmaceuticas que los contienen y un proceso para la preparacion de dichos derivados y el uso de dichos derivados para la preparacion de una composicion farmaceutica
PE20090880A1 (es) Compuestos heterociclicos como inhibidores de fosfatidilinositol 3-cinasa
MX2012006026A (es) Derivados de acido 5-alquinil-tiofen-2-carboxilico y usos para tratamiento o prevencion de infecciones por flavivirus.

Legal Events

Date Code Title Description
FD Application declared void or lapsed